Literature DB >> 8335356

The genes encoding the secreted aspartyl proteinases of Candida albicans constitute a family with at least three members.

B B Magee1, B Hube, R J Wright, P J Sullivan, P T Magee.   

Abstract

The secreted aspartyl proteinase activity from Candida albicans is thought to be a potential virulence factor. Four laboratories have cloned a gene from C. albicans encoding this enzyme. When two of these genes sharing 77% homology at the DNA level are hybridized under conditions of high stringency to contour-clamped homogeneous electric field chromosome separations of four different strains, they label different chromosomes: chromosome 6 for SAP1 and chromosome R for SAP2. The existence of different genes for the two sequences was confirmed by polymerase chain reaction. Genomic Southern blots probed with the genes and washed at low stringency revealed several cross-hybridizing bands. Contour-clamped homogeneous electric field chromosome separations probed at low stringency indicated that there was a cross-hybridizing sequence on chromosome 3 in addition to those on chromosomes R and 6. The genes for the secreted aspartyl proteinase activity in C. albicans thus constitute a gene family which we have called the SAP family.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335356      PMCID: PMC280994          DOI: 10.1128/iai.61.8.3240-3243.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Opaque-white phenotype transition: a programmed morphological transition in Candida albicans.

Authors:  E H Rikkerink; B B Magee; P T Magee
Journal:  J Bacteriol       Date:  1988-02       Impact factor: 3.490

2.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

3.  Proteolysis and pathogenicity of Candida albicans strains.

Authors:  F Staib
Journal:  Mycopathol Mycol Appl       Date:  1969-05-28

4.  Genetic evidence for role of extracellular proteinase in virulence of Candida albicans.

Authors:  K J Kwon-Chung; D Lehman; C Good; P T Magee
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

5.  "White-opaque transition": a second high-frequency switching system in Candida albicans.

Authors:  B Slutsky; M Staebell; J Anderson; L Risen; M Pfaller; D R Soll
Journal:  J Bacteriol       Date:  1987-01       Impact factor: 3.490

6.  High-frequency switching of colony morphology in Candida albicans.

Authors:  B Slutsky; J Buffo; D R Soll
Journal:  Science       Date:  1985-11-08       Impact factor: 47.728

7.  Strain and species identification by restriction fragment length polymorphisms in the ribosomal DNA repeat of Candida species.

Authors:  B B Magee; T M D'Souza; P T Magee
Journal:  J Bacteriol       Date:  1987-04       Impact factor: 3.490

8.  Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa.

Authors:  M Borg; R Rüchel
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

9.  cDNA cloning of an aspartic proteinase secreted by Candida albicans.

Authors:  H Mukai; O Takeda; K Asada; I Kato; S Y Murayama; H Yamaguchi
Journal:  Microbiol Immunol       Date:  1992       Impact factor: 1.955

10.  Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant.

Authors:  F Macdonald; F C Odds
Journal:  J Gen Microbiol       Date:  1983-02
View more
  16 in total

Review 1.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

2.  History of medical mycology in the united states.

Authors:  A Espinel-Ingroff
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

Review 3.  Budding off: bringing functional genomics to Candida albicans.

Authors:  Matthew Z Anderson; Richard J Bennett
Journal:  Brief Funct Genomics       Date:  2015-09-30       Impact factor: 4.241

4.  Proteolytic activation of the interleukin-1beta precursor by Candida albicans.

Authors:  A Beauséjour; D Grenier; J P Goulet; N Deslauriers
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

Review 5.  The role of Candida albicans secreted aspartic proteinase in the development of candidoses.

Authors:  L Hoegl; M Ollert; H C Korting
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

6.  Molecular cloning of the cDNA and gene for an elastinolytic aspartic proteinase from Aspergillus fumigatus and evidence of its secretion by the fungus during invasion of the host lung.

Authors:  J D Lee; P E Kolattukudy
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents.

Authors:  C Abad-Zapatero; R Goldman; S W Muchmore; C Hutchins; K Stewart; J Navaza; C D Payne; T L Ray
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

8.  Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients.

Authors:  M W Ollert; C Wende; M Görlich; C G McMullan-Vogel; M Borg-von Zepelin; C W Vogel; H C Korting
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

9.  Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis.

Authors:  F De Bernardis; A Cassone; J Sturtevant; R Calderone
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus.

Authors:  F De Bernardis; P Chiani; M Ciccozzi; G Pellegrini; T Ceddia; G D'Offizzi; I Quinti; P A Sullivan; A Cassone
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.